BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Promising clinical data for GVAX reported at scientific meeting
May 17, 1996
Human Genome Sciences claims chemokine beta-9 polypeptides and their antagonists
May 17, 1996
Melacine NDA filing in sight
May 10, 1996
Jenner Technologies in-licenses MTP-PE from Ciba
May 10, 1996
Allovectin-7 clinical results announced at AACR
May 3, 1996
Somatix receives patent coverage for GVAX
May 3, 1996
Preclinical results for DC101 presented at AACR
April 26, 1996
GVAX cleared to enter phase III testing
April 26, 1996
Mitsubishi in-licenses anti-HER2, will begin clinical evaluation soon
April 26, 1996
Alnorin reported in phase I
April 19, 1996
Previous
1
2
…
1001
1002
1003
1004
1005
1006
1007
1008
1009
Next
RSS